Madhusmita Behera Selected Research

Madhusmita Behera Research Topics

Disease

19	Neoplasms (Cancer) 01/2022 - 03/2013
13	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2022 - 08/2012
7	Lung Neoplasms (Lung Cancer) 01/2022 - 03/2014
5	Adenocarcinoma 03/2021 - 08/2015
4	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 11/2019 - 05/2012
3	Pneumonia (Pneumonitis) 01/2020 - 08/2017
3	Adenocarcinoma of Lung 11/2017 - 01/2017
2	Colorectal Neoplasms (Colorectal Cancer) 02/2021 - 01/2021
2	Neoplasm Metastasis (Metastasis) 01/2020 - 01/2019
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 11/2017 - 01/2017
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 11/2017 - 09/2014
1	Sarcoma (Soft Tissue Sarcoma) 01/2022
1	Carcinoid Tumor (Carcinoid) 03/2021
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2020
1	Colonic Neoplasms (Colon Cancer) 01/2020
1	Glioblastoma (Glioblastoma Multiforme) 01/2020
1	Brain Neoplasms (Brain Tumor) 11/2019
1	Breast Neoplasms (Breast Cancer) 01/2019
1	Margins of Excision 01/2019
1	Neoplasm Micrometastasis 01/2019
1	Squamous Cell Carcinoma of Head and Neck 01/2019
1	Cardiovascular Diseases (Cardiovascular Disease) 10/2018
1	Pancreatic Neoplasms (Pancreatic Cancer) 04/2018
1	Dysbiosis 01/2018
1	Infections 01/2018
1	Esophagitis 08/2017
1	Nausea 08/2017
1	Neutropenia 08/2017
1	Vomiting 08/2017
1	Hodgkin Disease (Hodgkin's Disease) 01/2017
1	Carcinogenesis 03/2014
1	Immunoglobulin Light-chain Amyloidosis 08/2009

Drug/Important Bio-Agent (IBA)

3	Proteins (Proteins, Gene)FDA Link 12/2019 - 03/2014
3	ErbB Receptors (EGF Receptor)IBA 01/2019 - 03/2016
2	Immune Checkpoint InhibitorsIBA 01/2020 - 01/2018
2	Cisplatin (Platino)FDA LinkGeneric 01/2019 - 08/2017
2	human ERBB2 proteinIBA 11/2017 - 03/2016
2	taxaneIBA 08/2015 - 09/2014
2	Everolimus FDA Link 04/2015 - 03/2013
2	DNA (Deoxyribonucleic Acid)IBA 04/2015 - 03/2014
1	Fibric Acids (Fibrates)IBA 05/2022
1	osimertinibIBA 01/2022
1	MRX-2843IBA 01/2022
1	c-Mer Tyrosine KinaseIBA 01/2022
1	LigandsIBA 01/2022
1	bcl-2 Homologous Antagonist-Killer Protein (bcl 2 Homologous Antagonist Killer Protein)IBA 01/2021
1	venetoclaxIBA 01/2021
1	Antineoplastic Agents (Antineoplastics)IBA 01/2021
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2020
1	Small Interfering RNA (siRNA)IBA 12/2019
1	Phosphotransferases (Kinase)IBA 12/2019
1	Ribonucleotide Reductases (Ribonucleotide Reductase)IBA 01/2019
1	Estrogen ReceptorsIBA 01/2019
1	Hormones (Hormone)IBA 01/2019
1	Biomarkers (Surrogate Marker)IBA 09/2018
1	Programmed Cell Death 1 ReceptorIBA 01/2018
1	B7-H1 AntigenIBA 01/2018
1	PrebioticsIBA 01/2018
1	Monoclonal AntibodiesIBA 01/2018
1	Rituximab (Mabthera)FDA Link 11/2017
1	AnthracyclinesIBA 11/2017
1	ORALIT (ORS)IBA 11/2017
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 10/2017
1	TensinsIBA 10/2017
1	Carboplatin (JM8)FDA LinkGeneric 08/2017
1	Etoposide (VP 16)FDA LinkGeneric 08/2017
1	Paclitaxel (Taxol)FDA LinkGeneric 08/2017
1	Focal Adhesion Protein-Tyrosine KinasesIBA 01/2017
1	CollagenIBA 01/2017
1	Protons (Proton)IBA 01/2017
1	Anaplastic Lymphoma KinaseIBA 03/2016
1	Bevacizumab (Avastin)FDA Link 08/2015
1	MTOR InhibitorsIBA 04/2015
1	RNA (Ribonucleic Acid)IBA 04/2015
1	Deoxyglucose (2 Deoxy D glucose)IBA 04/2015
1	SmokeIBA 03/2014
1	MethyltransferasesIBA 03/2014
1	CarcinogensIBA 03/2014
1	Histone Deacetylases (Histone Deacetylase)IBA 03/2014
1	Docetaxel (Taxotere)FDA Link 03/2013
1	Eukaryotic Initiation Factor-4EIBA 03/2013
1	TOR Serine-Threonine KinasesIBA 03/2013
1	Cytotoxins (Cytolysins)IBA 01/2013

Therapy/Procedure

14	Therapeutics 01/2022 - 08/2012
8	Drug Therapy (Chemotherapy) 02/2021 - 08/2009
7	Radiotherapy 03/2021 - 01/2017
3	Adjuvant Chemotherapy 03/2021 - 01/2020
2	Chemoradiotherapy 01/2020 - 01/2019
1	Immunotherapy 05/2022
1	Aftercare (After-Treatment) 01/2022
1	Metastasectomy 01/2022
1	Neoadjuvant Therapy 01/2019
1	Length of Stay 04/2015
1	Chemoprevention 03/2014
1	Salvage Therapy 03/2013
1	Cell Transplantation 08/2009